Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.
暂无分享,去创建一个
R. Ponzone | F. Montemurro | V. Rossi | M. Aglietta | P. Berchialla | I. Sarotto | S. Redana | F. Kubatzki | F. Maggiorotto | R. Martinello | G. Valabrega | Nicoletta Tomasi